HKEX: 3347 - Hangzhou Tigermed Consulting Co., Ltd

Yield per half year: +31.47%
Dividend yield: +3.91%
Sector: Healthcare

Hangzhou Tigermed Consulting Co., Ltd

63.0063.0054.0054.0045.0045.0036.0036.0027.0027.0018.0018.00Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
12.89 36.59 -64.77% 38.88 -66.84%
P/S 3.53 7.13 -50.45%
P/BV 1.07 3.66 -70.8%
P/FCF 73.77 -11.82 -724.3%
Ev/Ebitda 21.43 2.91 636.96%
Ev/S 7.68 19.3 -60.2%
Ev/FCF 67.8 -7.89 -959.73%
E/P 0.0328 0.0325 1.04%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
39.68 -9.7 -509.06% 52.28 -24.1%
ROE 9.96 4.42 125.42%
ROA 7.09 2.95 140.38%
ROIC 0 0 0%
ROS 27.42 -11.15 -345.96%
ROCE 0 0.1527 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.9659 0.7677 25.81% 0.6314 +52.97%
Nеt Debt/Ebitda 0 0.0174 -100%
Debt/Ratio 0.0953 0.1212 -21.35%
Debt/Equity 1.77 0.8042 120.07%
Debt/Net Income 1.4 1.54 -9.06%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
9.78/10
3.91 5.7 -31.4% 1.62 +140.72%
Number of years of dividend growth 3 1.13 166.67%
DSI 1 0.5838 71.29%
Average dividend growth 30.58 3.2 854.84%
Average percentage for 5 years 1.62 4.95 -67.2%
Average percentage for payments 25.01 24.82 0.7834%
Difference from average difference in sector -1.79

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
163.4 1.85 8732.43%
Growth impulse Ebitda in 5 years 145.56 -44.43 -427.62%
Growth impulse Net Income in 5 years 140.59 58.07 142.1%
Growth impulse FCF in 5 years 97.03 -7.48 -1397.19%
Growth impulse EPS in 5 years 11.06 -198.43 -105.57%
IP Score
6.59/10

Similar companies

Sinopharm Group Co. Ltd.

Hansoh Pharmaceutical Group Company Limited

WuXi AppTec Co., Ltd.

CSPC Pharmaceutical Group Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription